Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Angion Biomedica Corp
(NQ:
ANGN
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Jun 1, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Angion Biomedica Corp
< Previous
1
2
3
Next >
Why Hibbett Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
May 26, 2023
Gainers Onfolio Holdings, Inc. (NASDAQ: ONFO) gained 73% to $2.02 after the company announced it completed development of a generative AI search tool.
Via
Benzinga
Why Gap Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket
May 26, 2023
Gainers Oncorus, Inc. (NASDAQ: ONCR) shares rose 90% to $0.38 in pre-market trading after dropping around 17% on Thursday. Oncorus recently posted a narrower-than-expected quarterly loss.
Via
Benzinga
HC Wainwright Downgrades Angion Biomedica
July 18, 2022
Via
Benzinga
Angion Biomedica Pulls The Plug On Another Kidney Disease Trial - Read Why
June 30, 2022
Via
Benzinga
Why CohBar Shares Are Trading Lower By 161%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
May 23, 2023
Gainers
Via
Benzinga
Why Levi Strauss Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
April 06, 2023
Gainers Liquid Media Group Ltd. (NASDAQ: YVR) jumped 88.1% to $0.2719.
Via
Benzinga
Why Glory Star New Media Group Shares Are Trading Higher By 122%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
April 18, 2023
Gainers Glory Star New Media Group Holdings Limited (NASDAQ: GSMG) shares jumped 122% to $1.07 after the company announced the signing of a $60 million strategic investment with two institutional...
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
January 18, 2023
On Wednesday, 7 stocks made new 52-week lows.
Via
Benzinga
Nasdaq Edges Higher; Neovasc Shares Jump
January 17, 2023
U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite turning higher on Tuesday.
Via
Benzinga
Why Kodiak Sciences Shares Are Trading Higher By 18%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
March 29, 2023
Gainers LogicMark, Inc. (NASDAQ: LGMK) shares jumped 76.1% to $0.2466 after the company announced financial results for the year ended 2022. The company reported FY22 revenue of $11.9 million.
Via
Benzinga
Dow Tumbles 300 Points; Morgan Stanley Beats Q4 Views
January 17, 2023
U.S. stocks traded mostly lower midway through trading, with the Dow Jones dropping over 300 points on Tuesday.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
January 17, 2023
We're starting off Tuesday with a look at the biggest pre-market stock movers that traders will want to keep an eye on today!
Via
InvestorPlace
Stocks That Hit 52-Week Lows On Tuesday
March 21, 2023
On Tuesday, 74 companies achieved new lows for the year.
Via
Benzinga
Angion Biomedica's Return On Capital Employed Overview
September 12, 2022
According to Benzinga Pro data, during Q2, Angion Biomedica (NASDAQ:ANGN) posted sales of $653 thousand. Earnings were up 35.82%, but Angion Biomedica still reported an overall loss of $9.14 million.
Via
Benzinga
Recap: Angion Biomedica Q2 Earnings
August 15, 2022
Angion Biomedica (NASDAQ:ANGN) reported its Q2 earnings results on Monday, August 15, 2022 at 04:00 PM. Here's what investors need to know about the announcement.
Via
Benzinga
Why Calyxt Shares Are Trading Higher By Around 116%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
January 17, 2023
Gainers Celyad Oncology SA (NASDAQ: CYAD) jumped 187% to $2.30 after gaining 21% on Friday. Celyad Oncology, last month, decided to discontinue the development of its remaining clinical program...
Via
Benzinga
Daily Biotech Pulse: EU Approval For AbbVie's Ulcerative Colitis Treatment, Angion Biomedica Evaluates Alternatives, Clinical Hold For Immuron's Bacterial Infection Candidate
July 26, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
July 25, 2022
On Monday, 100 companies reached new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
July 19, 2022
Tuesday saw 37 companies set new 52-week lows.
Via
Benzinga
Akerna Shares Dip 53%, Here's 78 Biggest Movers From Yesterday
July 01, 2022
Gainers Revelation Biosciences, Inc. (NASDAQ: REVB) surged 77.4% to close at $1.11 on Thursday after jumping 27% on Wednesday. Revelation Biosciences recently announced completion of dosing for Phase...
Via
Benzinga
Nasdaq Down 100 Points; Angion Biomedica Shares Plummet
June 30, 2022
U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dropping over 100 points on Thursday.
Via
Benzinga
Dow Drops 250 Points; Rapid Micro Biosystems Shares Spike Higher
June 30, 2022
U.S. stocks traded lower midway through trading, with the Dow Jones dropping around 250 points on Thursday.
Via
Benzinga
Why Is NeuroSense Therapeutics Jumping By 45%? 64 Stocks Moving In Thursday's Mid-Day Session
June 30, 2022
Gainers Revelation Biosciences, Inc. (NASDAQ: REVB) jumped 171.3% to $1.70 after jumping 27% on Wednesday. Revelation Biosciences recently announced completion of dosing for Phase 1b CLEAR clinical...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 30, 2022
June 30, 2022
Upgrades
Via
Benzinga
The Daily Biotech Pulse: Pfizer/BioNTech Ink New COVID-19 Vaccine Supply Pact, Sanofi Hit By FDA Clinical Hold, Angion Biomedica Halts Second Kidney Disease Trial
June 30, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
76 Biggest Movers From Yesterday: Ocean Bio-Chem, Athira Pharma And More
June 23, 2022
Gainers Ocean Bio-Chem, Inc. (NASDAQ: OBCI) shares climbed 117.2% to close at $12.86 on Wednesday after the company announced it will be acquired by OneWater Marine for $13.08 per share in cash.
Via
Benzinga
Angion Biomedica's Return On Capital Employed Overview
June 22, 2022
Benzinga Pro data, Angion Biomedica (NASDAQ:ANGN) reported Q1 sales of $1.65 million. Earnings fell to a loss of $14.24 million, resulting in a 195.63% decrease from last quarter.
Via
Benzinga
79 Biggest Movers From Yesterday
June 08, 2022
Gainers AeroClean Technologies, Inc. (NASDAQ: AERC) gained 154.7% to settle at $12.10 on Tuesday on continued strength after the FDA granted clearance for the company's pūrgo technology, classifying it...
Via
Benzinga
Angion Biomedica: Q1 Earnings Insights
May 16, 2022
Angion Biomedica (NASDAQ:ANGN) reported its Q1 earnings results on Monday, May 16, 2022 at 04:05 PM. Here's what investors need to know about the announcement.
Via
Benzinga
77 Biggest Movers From Yesterday
June 01, 2022
Gainers TherapeuticsMD, Inc. (NASDAQ: TXMD) shares climbed 364% to close at $9.93 on Tuesday after the company announced it has entered into a definitive merger agreement to be acquired by an affiliate...
Via
Benzinga
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.